Literature DB >> 36170251

Do amyloid fibrils induce inflammation, or does inflammation generate amyloid fibrils?

Jonathan B Rothbard1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 36170251      PMCID： PMC9546591          DOI： 10.1073/pnas.2213903119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   12.779


× No keyword cloud information.
  13 in total

1.  Anti-amyloid failures stack up as Alzheimer antibody flops.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2019-04-05       Impact factor: 84.694

2.  Crystallographic structure of an intact IgG1 monoclonal antibody.

Authors:  L J Harris; E Skaletsky; A McPherson
Journal:  J Mol Biol       Date:  1998-02-06       Impact factor: 5.469

3.  TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.

Authors: 
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

4.  Solution of the structure of the TNF-TNFR2 complex.

Authors:  Yohei Mukai; Teruya Nakamura; Mai Yoshikawa; Yasuo Yoshioka; Shin-ichi Tsunoda; Shinsaku Nakagawa; Yuriko Yamagata; Yasuo Tsutsumi
Journal:  Sci Signal       Date:  2010-11-16       Impact factor: 8.192

Review 5.  NLRP3 inflammasome in neurodegenerative disease.

Authors:  Faith L Anderson; Karl E Biggs; Brynn E Rankin; Matthew C Havrda
Journal:  Transl Res       Date:  2022-08-08       Impact factor: 10.171

6.  The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor.

Authors:  M Grell; E Douni; H Wajant; M Löhden; M Clauss; B Maxeiner; S Georgopoulos; W Lesslauer; G Kollias; K Pfizenmaier; P Scheurich
Journal:  Cell       Date:  1995-12-01       Impact factor: 41.582

7.  Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors.

Authors:  H Loetscher; D Stueber; D Banner; F Mackay; W Lesslauer
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

8.  TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.

Authors:  Adam P Gregory; Calliope A Dendrou; Kathrine E Attfield; Aiden Haghikia; Dionysia K Xifara; Falk Butter; Gereon Poschmann; Gurman Kaur; Lydia Lambert; Oliver A Leach; Simone Prömel; Divya Punwani; James H Felce; Simon J Davis; Ralf Gold; Finn C Nielsen; Richard M Siegel; Matthias Mann; John I Bell; Gil McVean; Lars Fugger
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

Review 9.  Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer.

Authors:  Harald Wajant; Andreas Beilhack
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

10.  A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer's disease mouse model.

Authors:  Natalia Ortí-Casañ; Inge S Zuhorn; Petrus J W Naudé; Peter P De Deyn; Pauline E M van Schaik; Harald Wajant; Ulrich L M Eisel
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-29       Impact factor: 12.779
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.